有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Salmeterol;Salmaterol;SN-408;GR-33343X;Inaspir
Chemical Name (±)-2-(Hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
CAS 89365-50-4
Related CAS
Formula C25H37NO4
Structure
Formula Weight 415.57794
Stage 上市-1990
Company GlaxoSmithKline (Originator)
Activity/Mechanism Asthma Therapy, Bronchodilators, RESPIRATORY DRUGS, beta2-Adrenoceptor Agonists
Syn. Route 6
Route 1
the reaction of 4-phenyl-1-butanol (i) with 1,6-dibromohexane by means of nah in thf gives the ether derivative (iii), which is then condensed with 5-(2-amino-1-hydroxyethyl)-2-hydroxybenzyl alcohol (iv) by means of ki and triethylamine in hot dmf.
List of intermediates No.
acetonitrile (ii)
methyl 2-(8-amino-4-oxo-5,10-dihydro-4h-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate (i)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(2-hydroxy-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iii)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(4-methoxy-2-[[(trifluoromethyl)sulfonyl]oxy]phenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iv)
Reference 1:
    skidmore, i.f.; lunts, l.h.c.; finch, h.; naylor, a. (glaxo group ltd.); phenethanolamine derivs. be 0899448; de 3414752; es 8609209; fr 2545482; gb 2140800; gb 2176476; jp 1988264443; jp 1994087800; us 4992474; us 5091422 .

Route 2
the friedel-crafts condensation of 2-hydroxybenzoic acid methyl ester (i) with 13c-labeled acetyl chloride (ii) by means of alcl3 in dichloromethane gives 5-acetyl-2-hydroxybenzoic acid methyl ester (iii), which is brominated with br2 in chcl3 yielding the bromoacetyl compound (iv). the condensation of (iv) with the secondary amine (v) by means of diea in thf affords the tertiary amine (vi), which is reduced with liald4 in refluxing ethyl ether to provide the trideuterated triol (vii). finally, this compound is debenzylated by hydrogenation with h2 over pd/c in ethanol.
List of intermediates No.
3-amino-2,2-dimethylpropanamide (i)
5-iodo-2-[(2-methoxyethoxy)methoxy]benzaldehyde; 5-iodo-2-[(2-methoxyethoxy)methoxy]benzaldehyde (ii)
tert-butyl (1s)-2-hydrazino-1-(hydroxymethyl)-2-oxoethylcarbamate (iii)
1,1-dimethyl-2-propynyl 2-oxo-2-phenylacetate (iv)
1,1-dimethyl-2-propynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate (v)
[(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-(4-hydroxyphenyl)propanoate (vi)
(2s)-2-(bromomethyl)oxirane (vii)
2-(5-chloro-2-methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-2,4-dihydro-3h-1,2,4-triazol-3-one (ii)
4-{[6-(dimethylamino)hexyl]oxy}aniline; n-[6-(4-aminophenoxy)hexyl]-n,n-dimethylamine (iii)
ethyl 4-{[6-(dimethylamino)hexyl]oxy}phenyliminoformate (iv)
ethyl 3-({2-[(tert-butoxycarbonyl)amino]acetyl}amino)propanoate (vi)
ethyl 3-[(2-aminoacetyl)amino]propanoate (vii)
Reference 1:
    goodwin, t.e.; et al.; synthesis of 13c,2h3-salmeterol: an analytical internal standard for pharmacokinetic studies. j label compd radiopharm 2000, 43, 1, 65.

Route 3
the reaction of 4-phenyl-1-butanol (i) with 1,6-dibromohexane (ii) by means of koh and tetrabutylammonium bisulfate gives the butyl hexyl ether (iii), which is condensed with 2-aminoacetaldehyde dimethylacetal (iv) in refluxing toluene yielding 2-[6-(4-phenylbutoxy)hexylamino]acetaldehyde dimethylacetal (v). the protection of the amino group of (v) with n-(benzyloxycarbonyloxy)succinimide and triethylamine in acetone affords the carbamate (vi), which is treated with tsoh in acetone to provide the acetaldehyde derivative (vii). the condensation of (vii) with 6-bromo-2,2-dimethyl-1,3-benzodioxan (viii) (obtained by cyclization of phenol (ix) with acetone and alcl3) by means of mg in thf gives the expected carbinol (x), which is deprotected with h2 over pd/c in methanol yielding the aminoethanol derivative (xi). finally, this compound is treated with hcl in methanol/water to open the 1,3-dioxane ring and afford the target compound.
List of intermediates No.
acetonitrile (ii)
methyl 2-(8-amino-4-oxo-5,10-dihydro-4h-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate (i)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(2-hydroxy-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iii)
1-([[(2s,3r,4s)-7,7-dibromo-3-methoxy-2,4-dimethyl-6-heptenyl]oxy]methyl)benzene; benzyl (2s,3r,4s)-7,7-dibromo-3-methoxy-2,4-dimethyl-6-heptenyl ether (iv)
benzyl (2r,4r)-4-methyl-2-piperidinecarboxylate (v)
(vi)
(vii)
(viii)
[(1s,4r)-4-[2-amino-6-(cyclopropylamino)-9h-purin-9-yl]-2-cyclopenten-1-yl]methyl acetate (ix)
[(1s,4r)-4-[2-amino-6-(cyclopropylamino)-9h-purin-9-yl]-2-cyclopenten-1-yl]methyl methyl carbonate (x)
6-(methylamino)-5,6,7,8-tetrahydro-1,2-naphthalenediol (xi)
Reference 1:
    marquillas olondriz, f.; dalmases barjoan, p.; bessa bellmunt, j. (laboratorios vita, sa); new derivs. of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol. es 2142771; wo 0018722 .

Route 4
the condensation of n-benzyl-n-[6-(4-phenylbutoxy)hexyl]amine (i) with 5-(bromoacetyl)salicylaldehyde (ii) by means of tea in isopropanol gives the adduct (iii), which is debenzylated and reduced with h2 over pt/c and pd/c in ethanol to afford the target triol.
List of intermediates No.
1,1-dimethyl-2-propynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate (i)
[5-(4-methoxybenzoyl)-1h-pyrrol-3-yl](4-methoxyphenyl)methanone (ii)
ethyl 2-(2,4-bis{[4-(methyloxy)phenyl]carbonyl}-1h-pyrrol-1-yl)acetate (iii)
Reference 1:
    ariza aranda, j.; serra masià, j.; montserrat vidal, c. (laboratorios salvat sa); 6-[4-(phenylbutoxy)]hexylaminomethyl-4-hydroxy-alpha1,alpha3-benzenedimethanol. process for obtaining it and novel intermediates for its preparation. es 2065269 .

Route 5
the condensation of 1,6-dibromohexane (i) with 4-phenyl-1-butanol (ii) by means of naoh under phase transfer catalysis gives 6-(4-phenylbutoxy)hexyl bromide (iii), which is condensed with benzylamine (iv) by means of cs2co3 in hot dmf to yield the secondary amine (v). the condensation of (v) with methyl alpha-bromo 4-acetylsalicylate (vi) by means of diea in refluxing thf affords the tertiary amine (vii), which is submitted to a reductive deuteration by means of deuterated liald4 in thf to provide the trideuterated intermediate (viii). finally this compound is deprotected by hydrogenation with h2 over pd/c in methanol to give rise to the target trideuterated salmeterol.
List of intermediates No.
1-(2,6-dihydroxyphenyl)-1-ethanone (iv)
acetonitrile (i)
methyl 2-(8-amino-4-oxo-5,10-dihydro-4h-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate (ii)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(2-hydroxy-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iii)
1,1-dimethyl-2-propynyl 2-oxo-2-phenylacetate (v)
1,1-dimethyl-2-propynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate (vi)
[(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-(4-hydroxyphenyl)propanoate (vii)
(2s)-2-(bromomethyl)oxirane (viii)
Reference 1:
    molinski, t.f.; stanley, s.d.; improved synthesis of 13c,2h3- and 2h3-salmeterol by cs2co3-mediated monoalkylation of a primary amine. j label compd radiopharm 2002, 45, 9, 755.

Route 6
the condensation of 4-phenyl-1-butanol (i) with 1,6-dibromohexane (ii) by means of nah in thf gives the ether (iii), which is condensed with benzylamine (iv) by means of nai and tea in dmso to yield the secondary amine (v). the condensation of (v) with 5-(bromoacetyl)-2-hydroxybenzaldehyde (vi) in refluxing acetonitrile affords the tertiary amine (vii). the reduction of both carbonyl groups of (vii) by means of nabh4 in methanol affords the dihydroxy amine (viii), which is finally debenzylated by means of h2 over pd/c in the same solvent to provide the target salmeterol.the intermediate 5-(bromoacetyl)-2-hydroxybenzaldehyde (vi) has been obtained by friedel crafts condensation of 2-hydroxybenzaldehyde (ix) with bromoacetyl chloride (x) by means of alcl3 in dichloromethane.
List of intermediates No.
1-(2,6-dihydroxyphenyl)-1-ethanone (iv)
[(3r,4s)-1-benzyl-4-(5-bromo-2-methoxyphenyl)pyrrolidinyl]methanol (ix)
acetonitrile (ii)
methyl 2-(8-amino-4-oxo-5,10-dihydro-4h-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate (i)
5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide; 5-(n,n-dibenzylglycyl)salicylamide (x)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(2-hydroxy-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iii)
1,1-dimethyl-2-propynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate (v)
(2s)-2-(bromomethyl)oxirane (viii)
[5-(4-methoxybenzoyl)-1h-pyrrol-3-yl](4-methoxyphenyl)methanone (vi)
ethyl 2-(2,4-bis{[4-(methyloxy)phenyl]carbonyl}-1h-pyrrol-1-yl)acetate (vii)
Reference 1:
    rong, y.; ruoho, a.e.; a new synthetic approach to salmeterol. synth commun 1999, 29, 12, 2155.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名沙美特罗;英文名Salmeterol;Salmaterol;SN-408;GR-33343X;Inaspir;CAS[89365-50-4]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
唐山盛源泽兴化工有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
作物抗病基因工程新进展——利用
安道麦与辉丰强强联手,加深合作
2019年农药市场谁主沉浮?
用药拌干稻种可减轻恶苗病和干尖
原药登记中环境试验项目:环境归
2018年我国农药发展回顾与对
苏北沿海化企复产,前路还有多长
因抗药性,这些农药已失效了,怎
当前我国小麦主要病虫害发生面积
林丹,硫丹,全氟辛基磺酰氟,禁
检察机关:农资打假绝不手软!
颖泰/快达2018年业绩向好
草甘膦再评审即将开始!欧盟提议
干、抗、防!拜耳又一创新产品横
安道麦推出新产品,并将致力于完
环保压力不减,原药行情持续盘整
农业农村部×中化集团:携手共促
必须知道!这些问题在农药登记申
关于“三个时代”下我国农药发展
联化科技2019年第一季度净利
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明